Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 2 |
2019 | 2 |
2023 | 4 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.
N Engl J Med. 2023 Aug 17;389(7):589-601. doi: 10.1056/NEJMoa2304194. Epub 2023 Jun 4.
N Engl J Med. 2023.
PMID: 37272516
Clinical Trial.
Incidence and Outcome of Neurologic Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Patients With Melanoma.
Pepys J, Stoff R, Ramon-Gonen R, Ben-Betzalel G, Grynberg S, Frommer RS, Schachter J, Asher N, Taliansky A, Nikitin V, Dori A, Shelly S.
Pepys J, et al. Among authors: taliansky a.
Neurology. 2023 Dec 12;101(24):e2472-e2482. doi: 10.1212/WNL.0000000000207632. Epub 2023 Aug 31.
Neurology. 2023.
PMID: 37652699
Item in Clipboard
A phase 2 study of ibrutinib maintenance following first-line high-dose methotrexate-based chemotherapy for elderly patients with primary central nervous system lymphoma.
Bairey O, Taliansky A, Glik A, Amiel A, Yust-Katz S, Gurion R, Zektser M, Porges T, Sarid N, Horowitz NA, Shina TT, Lebel E, Cohen A, Geiger KR, Raanani P, Wolach O, Siegal T.
Bairey O, et al. Among authors: taliansky a.
Cancer. 2023 Dec 15;129(24):3905-3914. doi: 10.1002/cncr.34985. Epub 2023 Aug 12.
Cancer. 2023.
PMID: 37572086
Clinical Trial.
Item in Clipboard
A retrospective study of 222 patients with newly diagnosed primary central nervous system lymphoma-Outcomes indicative for improved survival overtime.
Bairey O, Lebel E, Buxbaum C, Porges T, Taliansky A, Gurion R, Goldschmidt N, Shina TT, Zektser M, Hofstetter L, Siegal T.
Bairey O, et al. Among authors: taliansky a.
Hematol Oncol. 2023 Dec;41(5):838-847. doi: 10.1002/hon.3198. Epub 2023 Jul 5.
Hematol Oncol. 2023.
PMID: 37403752
Item in Clipboard
Neurologic complications of immune checkpoint inhibitors.
Fellner A, Makranz C, Lotem M, Bokstein F, Taliansky A, Rosenberg S, Blumenthal DT, Mandel J, Fichman S, Kogan E, Steiner I, Siegal T, Lossos A, Yust-Katz S.
Fellner A, et al. Among authors: taliansky a.
J Neurooncol. 2018 May;137(3):601-609. doi: 10.1007/s11060-018-2752-5. Epub 2018 Jan 13.
J Neurooncol. 2018.
PMID: 29332184
Item in Clipboard
A large screen for paraneoplastic neurological autoantibodies; diagnosis and predictive values.
Seluk L, Taliansky A, Yonath H, Gilburd B, Amital H, Shoenfeld Y, Kivity S.
Seluk L, et al. Among authors: taliansky a.
Clin Immunol. 2019 Feb;199:29-36. doi: 10.1016/j.clim.2018.12.007. Epub 2018 Dec 10.
Clin Immunol. 2019.
PMID: 30543927
Item in Clipboard
Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study.
Bar J, Markel G, Gottfried T, Percik R, Leibowitz-Amit R, Berger R, Golan T, Daher S, Taliansky A, Dudnik E, Shulman K, Urban D, Onn A.
Bar J, et al. Among authors: taliansky a.
Eur J Cancer. 2019 Oct;120:122-131. doi: 10.1016/j.ejca.2019.06.021. Epub 2019 Sep 10.
Eur J Cancer. 2019.
PMID: 31518968
Clinical Trial.
Item in Clipboard
Cite
Cite